Aquamid

Key Takeaways

Aquamid is a permanent cross-linked polyacrylamide gel (2.5% polymer, 97.5% water) requiring explicit informed consent due to irreversibility and late-onset risk disclosure.

UK practitioners must comply with JCCP consent guidance and ensure comprehensive contraindication screening, particularly for patients with a history of autoimmune conditions or keloid formation.

Aquamid cannot be dissolved with hyaluronidase. Removal requires surgical intervention, so consent forms must explicitly state this irreversibility and potential migration risks.

Practice management software like Pabau streamlines consent documentation, ensuring every Aquamid procedure is captured with patient signature, risk acknowledgment, and secure audit trails for regulatory compliance.

Administering Aquamid requires meticulous documentation and informed consent. This template ensures your practice meets professional standards for permanent dermal filler procedures.

What is an Aquamid consent form?

An Aquamid consent form is a clinical document designed to ensure patients fully understand the risks, benefits, and irreversible nature of polyacrylamide gel filler treatment. All-in-one practice management software can streamline this documentation, but the form itself serves a critical legal and clinical purpose: Obtaining informed consent before treatment.

Aquamid is a permanent dermal filler composed of 2.5% cross-linked polyacrylamide suspended in 97.5% sterile water. Unlike hyaluronic acid fillers, such as those covered in our Teoxane consent form template, which dissolve naturally over 6-18 months, Aquamid remains in the tissue indefinitely. This permanence is why consent documentation must be thorough and legally robust.

A comprehensive dermal filler consent form template protects both practitioner and patient by documenting that the patient understands treatment goals, potential complications, and the inability to reverse the procedure chemically.

How to use this Aquamid consent form template

The template follows a structured five-step clinical workflow that mirrors best practice in aesthetic medicine:

1. Patient identification and medical history. Capture name, date of birth, contact information, and a detailed review of systems. Screen for contraindications including current keloid formation, autoimmune conditions (lupus, scleroderma), and allergies to polyacrylamide or lidocaine.
2. Treatment explanation section. Document the patient’s understanding of what Aquamid is, how it works (permanent scaffold in dermis), expected results (volume restoration over 2-4 weeks as surrounding tissue integrates), and realistic timelines for assessing outcomes, building on the discussion recorded in your aesthetic consultation notes.
3. Tiered risk disclosure: Absolute and relative contraindications. Absolute contraindications (active infection, immunosuppression, pregnancy) require the patient to decline treatment or obtain clearance from their physician. Relative contraindications (unrealistic expectations, history of adverse reactions to fillers, active acne) require documented discussion and patient acknowledgment of increased risk.
4. Consent declaration and specific risk acknowledgment. Patients must initial separate statements: “I understand Aquamid is permanent and cannot be dissolved with hyaluronidase,” “I understand risks include migration, granuloma formation, and late-onset inflammatory reactions,” and “I understand removal requires surgical intervention.”
5. Signature blocks and aftercare agreement. Patient and practitioner signatures (or electronic equivalent via Pabau’s patient intake software), dated consent, and confirmation that aftercare instructions, similar in format to our aftercare instructions template, were provided and understood.

Store the completed form in your patient record system with secure access controls and audit trails to demonstrate GDPR and professional accountability compliance.

Who is the Aquamid consent form helpful for?

This template suits any aesthetic practitioner administering Aquamid, particularly:

• Skin and dermatology practices — particularly those offering permanent or semi-permanent facial augmentation, often alongside a dermatology consent form.
• Medical spa teams — practices combining aesthetic treatments with broader wellness services.
• Aesthetic nurse practitioners and registered medical aestheticians — independent or practice-based practitioners operating under medical director oversight.
• Cosmetic surgery centers — facilities offering facial lipoatrophy correction or body contouring with permanent fillers, typically paired with a cosmetic surgery consent form.
• Private aesthetic practices in the UK and Europe — Aquamid is CE marked but not FDA approved, so this form is particularly relevant for UK and European practitioners.

Related Pabau consent and intake templates:

• Bariatric intake form
• Chemical peel consent form
• Botulinum toxin consent form
• Aqualyx consent form
• Laser hair removal informed consent form

Benefits of using this Aquamid consent form

Legal protection. Documented informed consent is your strongest defense against negligence claims. A patient who has initialed their understanding of irreversibility and risks has limited grounds to claim surprise or lack of disclosure later.

Regulatory compliance. The JCCP (Joint Council for Cosmetic Practitioners) requires documented consent covering the permanent nature of Aquamid, procedural risks, and post-treatment expectations. This template meets those standards.

Clinical safety. The contraindication screening section prevents treatment in high-risk patients and ensures pre-treatment medical clearance is documented where needed. This reduces complications and liability.

Audit readiness. Compliance management systems track consent forms, signature dates, and amendments. This audit trail demonstrates accountability during regulatory inspection or peer review.

Patient confidence. A thorough, professional consent form signals that your practice takes safety seriously. Patients appreciate transparency about realistic outcomes and honest risk disclosure.

Managing late-onset complications and permanence disclosure

Aquamid carries documented risks of late-onset complications including biofilm formation, granulomas, and inflammatory reactions that may emerge months or years after injection. Your consent form must explicitly list these risks so patients understand that adverse effects can occur long after treatment and require clinical management.

Unlike hyaluronic acid fillers, which naturally metabolize, Aquamid remains permanently unless surgically removed. This means a patient dissatisfied with results, experiencing migration, or developing complications cannot simply wait for the filler to dissolve.

Because Aquamid is permanent, your consent record for it should be treated as a long-term legal document. GDPR governs how that record itself must be securely stored and accessed, not the filler’s permanence in the patient’s body.

Ensure your form explicitly states: “Aquamid cannot be dissolved with hyaluronidase and removal requires surgical intervention.” This single statement prevents later claims of non-disclosure.

Regulatory status and geographic considerations

Aquamid is CE marked in Europe and the UK but not FDA approved in the United States. If your practice operates across jurisdictions, your consent form should reference the relevant regulatory status.

UK and European practitioners can cite CE conformity as evidence of safety. US practitioners using Aquamid, however, are administering an unapproved product and must disclose this status explicitly in consent documentation.

Professional guidance from JCCP and Save Face (UK cosmetic procedure accreditation) emphasizes that consent forms must reflect regulatory approvals and limitations in your jurisdiction. Adapt the template to your local regulatory environment before use.

Integrating Aquamid consent into your clinical workflow

Paper consent forms are no longer standard practice. Modern aesthetic practices are moving to digital consent workflows that capture patient signature, date-time stamps, and audit trails automatically. This proves the patient reviewed and consented, and creates a permanent record.

Digital systems also let you version-control your consent form. If clinical evidence or regulatory guidance changes, for example when new late-onset complications are published, you can update the form so all future patients see the latest version, while older consent records remain unaltered for audit purposes.

Store the completed form in your patient’s clinical record with the same security protections you apply to photographs, medical history, and treatment notes. It is a legal document and must be preserved for a minimum of 8 years, the NHS Records Management Code of Practice minimum for adult UK clinical records.

See how Pabau streamlines consent workflows

Pabau's digital forms system captures patient consent, signature, and audit trails automatically, with no paper, no lost documents, and full regulatory compliance.

Book a demo

Conclusion

An Aquamid consent form is a fundamental part of safe, ethical aesthetic practice. Documenting informed consent, contraindication screening, and explicit risk acknowledgment protects your practice, your reputation, and your patients. Download this template, adapt it to your jurisdiction and clinical setting, and integrate it into your cosmetic and aesthetic surgery workflows today.

Continue your research

Need streamlined patient intake? Pabau’s patient records system securely stores consent forms, medical history, and treatment notes in one searchable database.

Looking for regulatory guidance on consent? Aesthetics Journal publishes clinical case studies on delayed-onset filler complications and best-practice consent frameworks.

Want to learn more about permanent fillers? Contura, Aquamid’s manufacturer provides clinical data, injection protocols, and regulatory documentation for practitioners.

Frequently asked questions